Updated results of a study examining brentuximab vedotin combined with chemotherapy for first line treatment of Hodgkin lymphoma.
Home / Resource Library / Brentuximab vedotin with chemotherapy for stage III/IV classical Hodgkin lymphoma: 3-year update of the ECHELON-1 study